Izotropic Corp

Izotropic Corp completes private placement and debt settlement, boosting its balance sheet and future prospects.

Izotropic Corp’s Q1 results reveal a volatile CAD 0.285 stock, negative P/E and P/B ratios, and a $20M market cap—showing a company at a crossroads of risk and opportunity.

Izotropic Corp’s Jan‑2026 quarterly results reveal a volatile CAD 0.29 close amid a -6.8 PE ratio, showing resilience yet cautious investor sentiment on the Canadian National Stock Exchange.

Izotropic Corp’s Canadian stock struggles: low price, negative earnings, and a new unit release to cover note interest. Understand the risks and market outlook.

Izotropic Corp’s recent unit issuance to cover note interest reveals its liquidity strategy amid volatile trading, low P/E and P/B ratios, underscoring the company’s restructuring efforts and market resilience.

Izotropic Corp’s stock plummets to $0.305 CAD amid negative P/E and P/B ratios; the company focuses on debt‑servicing, not growth, as investors watch its volatile performance.

Izotropic Corp’s stock slump to 0.305 CAD, negative P/E and flat market cap reveal deep financial distress—investors urged to scrutinize its strategy and prospects.

Izotropic Corp’s volatile stock swings, negative P/E, and modest cap signal a challenging yet growth‑potential Canadian tech firm—investors eye strategic moves for future value.

Izotropic Corp, a Canadian company listed on the Canadian National Stock Exchange, is facing significant financial challenges, including a negative price-to-earnings ratio and a 52-week low stock price, raising questions about its viability and futu…

Izotropic Corp’s stock price has fluctuated significantly, with a current price of 0.27 CAD, amidst challenges and a negative price-to-earnings ratio.